Though no definitive conclusions can be drawn from these results, they are consistent with the possibility that motilin is associated with gastrointestinal symptoms in depressed patients, that changes in motilin levels may be a biomarker of response in patients with comorbid FD and depression and that some antidepressants may have a significant effect on the motilin levels. Here, MLN is linked to depressive symptom measurement.